Ono Pharmaceutical Co Ltd - Common Stock - Foreign

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / Common Stock - Foreign
Shares, excl. options Q3 2024
447K
Holdings value Q3 2024
$5.94M
Value change Q3 2024
-$32.3K
Grand Portfolio weight change Q3 2024
0%
Number of holders
1
Number of buys Q3 2024
0
Number of sells Q3 2024
-1
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 447K $5.94M -$32.3K $13.30 1
2024 Q2 449K $6.13M +$2.95M $13.65 1
2024 Q1 233K $3.81M +$509K $16.36 1
2023 Q4 202K $3.61M +$3.61M $17.84 1
2023 Q3 0 $0 -$2.29M 0
2023 Q2 127K $2.29M +$2.23M $18.06 1
2023 Q1 3.69K $76.8K +$2.44K $20.82 1
2022 Q4 3.57K $83.9K +$83.9K $23.49 1
2021 Q1 0 $0 -$825K 0
2020 Q4 27.4K $825K $0 $30.10 1
2020 Q3 27.4K $858K +$65.7K $31.31 1
2020 Q2 25.3K $736K $0 $29.08 1
2020 Q1 25.3K $583K +$242K $23.03 1
2019 Q4 14.8K $341K $0 $23.02 1
2019 Q3 14.8K $268K $0 $18.11 1
2019 Q2 14.8K $265K $0 $17.93 1
2019 Q1 14.8K $290K +$39.2K $19.60 1
2018 Q4 12.8K $262K $0 $20.46 1
2018 Q3 12.8K $362K $0 $28.30 1
2018 Q2 12.8K $300K $0 $23.45 1
2018 Q1 12.8K $396K $0 $30.97 1
2017 Q4 12.8K $298K $0 $23.31 1
2017 Q3 12.8K $290K $0 $22.65 1
2017 Q2 12.8K $279K $0 $21.81 1
2017 Q1 12.8K $265K +$234K $20.68 1
2016 Q4 1.5K $32.9K $0 $21.91 1
2016 Q3 1.5K $41.6K $0 $27.71 1
2016 Q2 1.5K $64.8K $0 $43.20 1
2016 Q1 1.5K $63.6K +$50.9K $42.40 1
2015 Q4 300 $54.1K +$54.1K $180.31 1